Estimating the burden of vaccine-preventable lower respiratory tract disease in UK primary care: protocol for a prospective surveillance study (AvonCAP GP2)

Polly Duncan; Ruth Mears; Elizabeth Begier; Sanaz Rouhbakhsh Halvaei; Jo Southern; Siân Bodfel Porter; Robin Hubler; Glenda Oben; George Qian; Maria Lahuerta; Tim Davis; James Campling; Shoba Dawson; Hannah Christensen; Jennifer Oliver; Begonia Morales-Aza; Kaijie Pan; Sharon Gray; Catherine Hyams; Leon Danon; Bradford D Gessner; Adam Finn; Alastair D Hay; AvonCAP GP2 research group

doi:10.3399/BJGPO.2024.0129

Protocol

Estimating the burden of vaccine-preventable lower respiratory tract disease in UK primary care: protocol for a prospective surveillance study (AvonCAP GP2)

Polly Duncan, Ruth Mears, Elizabeth Begier, Sanaz Rouhbakhsh Halvaei, Jo Southern, Siân Bodfel Porter, Robin Hubler, Glenda Oben, George Qian, Maria Lahuerta, Tim Davis, James Campling, Shoba Dawson, Hannah Christensen, Jennifer Oliver, Begonia Morales-Aza, Kaijie Pan, Sharon Gray, Catherine Hyams, Leon Danon, Bradford D Gessner, Adam Finn, Alastair D Hay and AvonCAP GP2 research group

BJGP Open 2024; 8 (4): BJGPO.2024.0129. DOI: https://doi.org/10.3399/BJGPO.2024.0129

Polly Duncan

1 Centre for Academic Primary Care, University of Bristol, Bristol, UK

2 Bristol Vaccine Centre, Schools of Population Health Science and Cellular and Molecular Medicine, University of Bristol, Bristol, UK

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
ORCID record for Polly Duncan
For correspondence: polly.duncan@bristol.ac.uk

Ruth Mears

1 Centre for Academic Primary Care, University of Bristol, Bristol, UK

2 Bristol Vaccine Centre, Schools of Population Health Science and Cellular and Molecular Medicine, University of Bristol, Bristol, UK

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Elizabeth Begier

3 Global Respiratory Vaccines, Medical & Scientific Affairs, Pfizer Inc, Collegeville, PA, US

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Sanaz Rouhbakhsh Halvaei

2 Bristol Vaccine Centre, Schools of Population Health Science and Cellular and Molecular Medicine, University of Bristol, Bristol, UK

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Jo Southern

4 Evidence Generation, Pfizer Inc, Collegeville, PA, US

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Siân Bodfel Porter

2 Bristol Vaccine Centre, Schools of Population Health Science and Cellular and Molecular Medicine, University of Bristol, Bristol, UK

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Robin Hubler

4 Evidence Generation, Pfizer Inc, Collegeville, PA, US

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Glenda Oben

2 Bristol Vaccine Centre, Schools of Population Health Science and Cellular and Molecular Medicine, University of Bristol, Bristol, UK

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

George Qian

2 Bristol Vaccine Centre, Schools of Population Health Science and Cellular and Molecular Medicine, University of Bristol, Bristol, UK

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Maria Lahuerta

3 Global Respiratory Vaccines, Medical & Scientific Affairs, Pfizer Inc, Collegeville, PA, US

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Tim Davis

1 Centre for Academic Primary Care, University of Bristol, Bristol, UK

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

James Campling

5 Vaccines Medical Affairs, Pfizer Ltd, Tadworth, UK

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Shoba Dawson

1 Centre for Academic Primary Care, University of Bristol, Bristol, UK

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Hannah Christensen

2 Bristol Vaccine Centre, Schools of Population Health Science and Cellular and Molecular Medicine, University of Bristol, Bristol, UK

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Jennifer Oliver

2 Bristol Vaccine Centre, Schools of Population Health Science and Cellular and Molecular Medicine, University of Bristol, Bristol, UK

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Begonia Morales-Aza

2 Bristol Vaccine Centre, Schools of Population Health Science and Cellular and Molecular Medicine, University of Bristol, Bristol, UK

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Kaijie Pan

6 EvGen Statistics, Pfizer Research and Development, Pfizer Inc, Collegeville, PA, US

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Sharon Gray

4 Evidence Generation, Pfizer Inc, Collegeville, PA, US

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Catherine Hyams

2 Bristol Vaccine Centre, Schools of Population Health Science and Cellular and Molecular Medicine, University of Bristol, Bristol, UK

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Leon Danon

7 School of Engineering Mathematics and Technology, University of Bristol, Bristol, UK

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Bradford D Gessner

3 Global Respiratory Vaccines, Medical & Scientific Affairs, Pfizer Inc, Collegeville, PA, US

8 West of England NIHR Clinical Research Network, Bristol, UK

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Adam Finn

2 Bristol Vaccine Centre, Schools of Population Health Science and Cellular and Molecular Medicine, University of Bristol, Bristol, UK

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Alastair D Hay

1 Centre for Academic Primary Care, University of Bristol, Bristol, UK

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Article
Figures & Data
Info
eLetters
PDF

Submit a Response to This Article

Compose eLetter

Title *

Contents

More information about text formats

Plain text

No HTML tags allowed.
Web page addresses and e-mail addresses turn into links automatically.
Lines and paragraphs break automatically.

Author Information

Contributors

First Name and Middle Initial *

First or given name, e.g. 'Peter'.

Last Name *

Your last, or family, name, e.g. 'MacMoody'.

Email Address *

Your email address, e.g. higgs-boson@gmail.com. PLEASE NOTE: your email address will be published.

Occupation *

Your role and/or occupation, e.g. 'Orthopedic Surgeon'.

Affiliation *

Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.

Statement of Competing Interests

Competing interests? *

Yes

Please describe the competing interests

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

Jump to comment:

No eLetters have been published for this article.

Previous ArticleNext Article

In this issue

BJGP Open

Vol. 8, Issue 4

December 2024

Table of Contents
Index by author

Download PDF

Download PowerPoint

Email Article

Thank you for recommending BJGP Open.

NOTE: We only request your email address so that the person to whom you are recommending the page knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Your Email *

Your Name *

Send To *

Enter multiple addresses on separate lines or separate them with commas.

You are going to email the following Estimating the burden of vaccine-preventable lower respiratory tract disease in UK primary care: protocol for a prospective surveillance study (AvonCAP GP2)

Message Subject (Your Name) has forwarded a page to you from BJGP Open

Message Body (Your Name) thought you would like to see this page from BJGP Open.

Your Personal Message

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Citation Tools

Estimating the burden of vaccine-preventable lower respiratory tract disease in UK primary care: protocol for a prospective surveillance study (AvonCAP GP2)

BJGP Open 2024; 8 (4): BJGPO.2024.0129. DOI: 10.3399/BJGPO.2024.0129

Citation Manager Formats

BibTeX
Bookends
EasyBib
EndNote (tagged)
EndNote 8 (xml)
Medlars
Mendeley
Papers
RefWorks Tagged
Ref Manager
RIS
Zotero

Estimating the burden of vaccine-preventable lower respiratory tract disease in UK primary care: protocol for a prospective surveillance study (AvonCAP GP2)

BJGP Open 2024; 8 (4): BJGPO.2024.0129. DOI: 10.3399/BJGPO.2024.0129

Share This Article:

Tweet Widget
Facebook Like
Google Plus One
Mendeley

Jump to section

Top
Article
Figures & Data
Info
eLetters
PDF

Keywords

Primary Health Care
lower respiratory tract infection
respiratory tract diseases
respiratory syncytial viruses

Cited By...

Intended for Healthcare Professionals

British Journal of General Practice

Main menu

User menu

Search

Estimating the burden of vaccine-preventable lower respiratory tract disease in UK primary care: protocol for a prospective surveillance study (AvonCAP GP2)

Plain text

Vertical Tabs

Jump to comment:

In this issue

Citation Manager Formats

Keywords

More in this TOC Section

Related Articles

Cited By...

NAVIGATE

RCGP

MY ACCOUNT

NEWS AND UPDATES

AUTHORS & REVIEWERS

CUSTOMER SERVICES

CONTRIBUTE

CONTACT US